GenomeIndia Reveals Significant Health Disparities Across India’s Diverse Populations The GenomeIndia (GI) project, launched in January 2020 as a national consortium under the Department of Biotechnology, has released findings that highlight a complex and uneven landscape of disease risk, drug response, and metabolic health across India’s diverse populations. The initiative, coordinated by the Centre for Brain Research at the Indian Institute of Science (IISc) in Bengaluru, involved collaboration with multiple institutions, including BRIC-NIBMG, CSIR-CCMB, and CSIR-IGIB, as well as sample-collection partners across the country. The project’s flagship genomics manuscript and a companion phenotypic manuscript, along with a public dashboard, open code, and supplementary materials, aim to address gaps in India’s representation in global genomic databases. However, the two principal papers remain preprints on medRxiv and have not undergone peer review, emphasizing the need for cautious interpretation of their findings. India, home to approximately 18% of the world’s population, has long been a demographic powerhouse in global health discussions. Yet, its genomic and phenotypic data have remained underrepresented in international research. The GI project seeks to rectify this by capturing the country’s internal diversity, shaped by thousands of ethnolinguistic groups, long histories of endogamy, and regional variations. The study’s focus is not ancestry but rather the potential of population-scale data to improve medical precision in a country as diverse as India. This includes refining disease risk interpretation, drug choice and dosing, and identifying groups overlooked by current screening systems.#bengaluru #genomeindia #department_of_biotechnology #centre_for_brain_research #indian_institute_of_science
